Quinsam Capital Corporation (CSE:QCA) shared an initial update with investors on the performance of the company during the second quarter of 2018.

As quoted in the press release:


New Investments

We invested $440,000 in units of MVC Technologies Inc., which operates as Sail Technologies.  The company offers cloud-based software solutions to the cannabis sector.  We expect the company to list in the fall of 2018.

We invested $300,000 in shares of Eve & Co. Incorporated at $0.25. These shares have commenced trading and are at a premium to our cost.  This company is a late stage ACMPR applicant.

We made a small investment in Hystyle Brands Inc. (“Hystyle”).  Hystyle is a subsidiary of Gilla Inc. that is focused on vape technology.  Gilla Inc. plans to spin this off to its shareholders as a new public company.  We obtained a very small allocation of Aldershot Resources Ltd., which is expected to trade as Solo Growth Corp. in the near term.  Solo Growth Corp. is an Alberta dispensary applicant.

“While the cannabis sector has shown and likely will show significant volatility, we still see many extremely interesting investment opportunities,” said Roger Dent.  “We will continue to look for opportunities that are generally unavailable to the typical investor.  We will also remain focused on maintaining a tight cost structure.  By bringing a disciplined approach to this rather volatile sector, we have to date been able to deliver strong results for our investors.”

Click here to read the full press release.

Source: globenewswire.com

Strong Innovation Pipeline Continues to Drive Market Share Growth
Broken Coast’s First Foray into Cannabis 2.0
Solei Introduces First Limited Release Vape on the Market
Solei, RIFF, Good Supply and B!NGO Expand Product Offerings

Aphria Inc. (” Aphria ” or the ” Company “) ( TSX: APHA and NASDAQ: APHA ), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, today announced the expansion of its 510 Vape offering across its award-winning adult-use brand portfolio.

Keep reading... Show less

Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”). If you wish to serve as lead plaintiff, you must move the Court before the December 1 2020 DEADLINE . A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=aurora-cannabis-inc&id=2437 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email info@zhanginvestorlaw.com for information on the class action.

Keep reading... Show less

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf Solutions“, “OILS”, or the “Company”), Canada’s most innovative cannabis extractor, is pleased to provide the following commercial and intellectual property update:

Cannabis Extraction Agreement with White Label Producer

Keep reading... Show less

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

Khiron Life Sciences Corp. (“ Khiron ” or, the “ Company ”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce that it has closed today its previously announced “bought deal” short form prospectus offering of units (“ Unit s ”), including the exercise in full of the over-allotment option (the “ Offering ”).

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, is scheduled to speak on a panel at the Cowen 2020 Boston Cannabis Conference on Wednesday, December 2, 2020 at 9:20 a.m. EST.

For more information regarding the Cowen 2020 Boston Cannabis Conference please visit: https://www.cowen.com/conferences-and-events/3rd-annual-boston-cannabis-conference/

Keep reading... Show less